why choose us

First received: July 31, 2023

Clinical Trial: Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults

Study Status: Completed

Recruit Status: RECRUITING

Condition: Influenza

Study Type: INTERVENTIONAL


Official Title: VRC 326 (001614): A Phase I Open-Label Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adul

Brief Summary: Background:Influenza (flu) virus causes 3 to 5 million cases of severe illness and up to 650,000 deaths per year worldwide.Current vaccines work well against single strains of flu virus.But no single vaccine works well against all flu viruses that can cause illness.Objective:To test an experimental flu vaccine (FluMos-v2) in healthy adults.Eligibility:Healthy adults aged 18 to 50 years.Design:Participants will have 11 clinic visits in 10 months.They must agree not to get a licensed flu vaccine while taking part in…

Read more